<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Recently several articles have reported the possible concomitant presence of respiratory pathogens in subjects with COVID-19. Viral and bacterial pathogens have been described in case reports, case series and four cohorts: a low prevalence was reported (1.6â€“6.5%), with the exception of a single recent report (24/116, 20.7%) [
 <xref rid="bib2" ref-type="bibr">2</xref>]. Phenomena like viral interference, common receptor usage, different inoculum size or simply resource competition might explain why dual or multiple concurrent viral respiratory infections are rare [
 <xref rid="bib3" ref-type="bibr">3</xref>,
 <xref rid="bib4" ref-type="bibr">4</xref>]. Few articles have addressed the clinical features of coinfected patients, with the relevant exception of a child with SARS-CoV-2, metapneumovirus and respiratory syncytial virus admitted to an intensive care unit, with no increased risk of severe disease reported [
 <xref rid="bib5" ref-type="bibr">5</xref>]. In line with this, a 9-year-old child included in the French Alps cluster was coinfected with SARS-CoV-2, rhinovirus/enterovirus and influenza H1N1 and asymptomatic, but no secondary cases were found among his contacts [
 <xref rid="bib6" ref-type="bibr">6</xref>].
</p>
